カテゴリー： GlobalInfoResearch, 世界, 医療/バイオ

ヒト顆粒球コロニー刺激因子の世界市場2022：300μg/回、150μg/回、75μg/回、その他

◆英語タイトル：Global Human Granulocyte Colony-stimulating Factor Market 2022 by Manufacturers, Regions, Type and Application, Forecast to 2028
	◆商品コード：GIR22DC3295 ◆発行会社（リサーチ会社）：GlobalInfoResearch ◆発行日：2023年1月 ◆ページ数：111 ◆レポート形式：英語 / PDF ◆納品方法：Eメール（注文後2-3日） ◆調査対象地域：グローバル ◆産業分野：医療

◆販売価格オプション（消費税別）

Single User（1名様閲覧用）	USD3,480 ⇒換算￥522,000	見積依頼/購入/質問フォーム
Multi User（20名様閲覧用）	USD5,220 ⇒換算￥783,000	見積依頼/購入/質問フォーム
Corporate User（同一法人内共有可）	USD6,960 ⇒換算￥1,044,000	見積依頼/購入/質問フォーム

★GlobalInfoResearchに受託調査の見積を依頼する

※販売価格オプションの説明はこちらで、ご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※Eメールによる納品の場合、通常ご注文当日～2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行・送付致します。（請求書発行日より2ヶ月以内の銀行振込条件、カード払いに変更可）
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。

❖ レポートの概要 ❖

世界のヒト顆粒球コロニー刺激因子市場レポートは、グローバル市場規模、地域および国レベルの市場規模、セグメント市場の成長性、市場シェア、競争環境、販売分析、国内および世界の市場プレーヤーの影響、バリューチェーンの最適化、最近の動向、機会分析、市場成長の戦略的な分析、製品発売、地域市場の拡大などに関する情報を提供します。
Global Info Research社の最新のリサーチによると、世界のヒト顆粒球コロニー刺激因子の市場規模は2021年のxxx米ドルから2028年にはxxx米ドルと推定され、xxx％の成長率で成長すると予想されます。

ヒト顆粒球コロニー刺激因子市場はタイプとアプリケーションによって区分されます。2017年～2028年において、量と金額の観点から種類別および用途別セグメントの売上予測データを提供します。この分析は、適格なニッチ市場をターゲットにすることでビジネスを拡大するのに役立ちます。

タイプ別セグメントは次をカバーします。
・300μg/回、150μg/回、75μg/回、その他

アプリケーション別セグメントは次のように区分されます。
・病院、診療所

世界のヒト顆粒球コロニー刺激因子市場の主要な市場プレーヤーは以下のとおりです。
・Chugai Pharmaceutical、Kyowa Hakko Kirin、Sanway、GenSci、SL PHARM、Kexing Bioproducts、Qilu Pharmaceutical、CSPC、Wuzhong Pharmaceutical、Quangang Pharmaceutical、Huabei Pharmaceutical、Harbin Pharmaceutical、Amoytop Biotech、Jiuyuan Gene Engineering、Four Rings Biopharmaceutical

地域別セグメントは次の地域・国をカバーします。
・北米（アメリカ、カナダ、メキシコ）
・欧州（ドイツ、フランス、イギリス、ロシア、イタリア）
・アジア（日本、中国、韓国、インド、東南アジア、オーストラリア）
・南米（ブラジル、アルゼンチン、コロンビア）
・中東/アフリカ（サウジアラビア、UAE、エジプト、南アフリカ）

本調査資料の内容は計15章あります。
・第1章では、ヒト顆粒球コロニー刺激因子製品の調査範囲、市場の概要、市場の成長要因・阻害要因、および市場動向について説明します。
・第2章では、主要なヒト顆粒球コロニー刺激因子メーカーの企業概要、2019年～2022年までのヒト顆粒球コロニー刺激因子の価格、販売量、売上、市場シェアを掲載しています。
・第3章では、主要なヒト顆粒球コロニー刺激因子メーカーの競争状況、販売量、売上、世界市場シェアが重点的に比較分析されています。
・第4章では、2017年～2028年までの地域別ヒト顆粒球コロニー刺激因子の販売量、売上、成長性を示しています。
・第5、6章では、2017年～2028年までのヒト顆粒球コロニー刺激因子の種類別と用途別の市場規模、市場シェアと成長率を掲載しています。
・第7、8、9、10、11章では、2017年～2022年までの世界の主要国での販売量、売上、市場シェア、並びに2023年～2028年までの主要地域でのヒト顆粒球コロニー刺激因子市場予測を収録しています。
・第12章では、主要な原材料、主要なサプライヤー、およびヒト顆粒球コロニー刺激因子の産業チェーンを掲載しています。
・第13、14、15章では、ヒト顆粒球コロニー刺激因子の販売チャネル、販売業者、顧客、調査結果と結論、付録、データソースなどについて説明します。

***** 目次(一部) *****

・市場概要
– ヒト顆粒球コロニー刺激因子の概要
– 種類別分析（2017年vs2021年vs2028年）：300μg/回、150μg/回、75μg/回、その他
– 用途別分析（2017年vs2021年vs2028年）：病院、診療所
– 世界のヒト顆粒球コロニー刺激因子市場規模・予測
– 世界のヒト顆粒球コロニー刺激因子生産能力分析
– 市場の成長要因・阻害要因・動向
・メーカー情報（企業概要、製品概要、販売量、価格、売上）
– Chugai Pharmaceutical、Kyowa Hakko Kirin、Sanway、GenSci、SL PHARM、Kexing Bioproducts、Qilu Pharmaceutical、CSPC、Wuzhong Pharmaceutical、Quangang Pharmaceutical、Huabei Pharmaceutical、Harbin Pharmaceutical、Amoytop Biotech、Jiuyuan Gene Engineering、Four Rings Biopharmaceutical
・メーカー別市場シェア・市場集中度
・地域別市場分析2017年-2028年
・種類別分析2017年-2028年：300μg/回、150μg/回、75μg/回、その他
・用途別分析2017年-2028年：病院、診療所
・ヒト顆粒球コロニー刺激因子の北米市場
– 種類別市場規模2017年-2028年
– 用途別市場規模2017年-2028年
– 主要国別市場規模：アメリカ、カナダ、メキシコなど
・ヒト顆粒球コロニー刺激因子のヨーロッパ市場
– 種類別市場規模2017年-2028年
– 用途別市場規模2017年-2028年
– 主要国別市場規模：ドイツ、イギリス、フランス、ロシア、イタリアなど
・ヒト顆粒球コロニー刺激因子のアジア市場
– 種類別市場規模2017年-2028年
– 用途別市場規模2017年-2028年
– 主要国別市場規模：中国、日本、韓国、インド、東南アジア、オーストラリアなど
・ヒト顆粒球コロニー刺激因子の南米市場
– 種類別市場規模2017年-2028年
– 用途別市場規模2017年-2028年
– 主要国別市場規模：ブラジル、アルゼンチンなど
・ヒト顆粒球コロニー刺激因子の中東・アフリカ市場
– 種類別市場規模2017年-2028年
– 用途別市場規模2017年-2028年
– 主要国別市場規模：サウジアラビア、トルコ、エジプト、南アフリカなど
・原材料および産業チェーン
・販売チャネル、流通業者・代理店、顧客リスト
・調査の結果・結論

❖ レポートの目次 ❖

1 Market Overview
1.1 Human Granulocyte Colony-stimulating Factor Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Human Granulocyte Colony-stimulating Factor Revenue by Type: 2017 Versus 2021 Versus 2028
1.2.2 300μg/Dose
1.2.3 150μg/Dose
1.2.4 75μg/Dose
1.2.5 Others
1.3 Market Analysis by Application
1.3.1 Overview: Global Human Granulocyte Colony-stimulating Factor Revenue by Application: 2017 Versus 2021 Versus 2028
1.3.2 Hospital
1.3.3 Clinic
1.4 Global Human Granulocyte Colony-stimulating Factor Market Size & Forecast
1.4.1 Global Human Granulocyte Colony-stimulating Factor Sales in Value (2017 & 2021 & 2028)
1.4.2 Global Human Granulocyte Colony-stimulating Factor Sales in Volume (2017-2028)
1.4.3 Global Human Granulocyte Colony-stimulating Factor Price (2017-2028)
1.5 Global Human Granulocyte Colony-stimulating Factor Production Capacity Analysis
1.5.1 Global Human Granulocyte Colony-stimulating Factor Total Production Capacity (2017-2028)
1.5.2 Global Human Granulocyte Colony-stimulating Factor Production Capacity by Geographic Region
1.6 Market Drivers, Restraints and Trends
1.6.1 Human Granulocyte Colony-stimulating Factor Market Drivers
1.6.2 Human Granulocyte Colony-stimulating Factor Market Restraints
1.6.3 Human Granulocyte Colony-stimulating Factor Trends Analysis
2 Manufacturers Profiles
2.1 Chugai Pharmaceutical
2.1.1 Chugai Pharmaceutical Details
2.1.2 Chugai Pharmaceutical Major Business
2.1.3 Chugai Pharmaceutical Human Granulocyte Colony-stimulating Factor Product and Services
2.1.4 Chugai Pharmaceutical Human Granulocyte Colony-stimulating Factor Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.2 Kyowa Hakko Kirin
2.2.1 Kyowa Hakko Kirin Details
2.2.2 Kyowa Hakko Kirin Major Business
2.2.3 Kyowa Hakko Kirin Human Granulocyte Colony-stimulating Factor Product and Services
2.2.4 Kyowa Hakko Kirin Human Granulocyte Colony-stimulating Factor Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.3 Sanway
2.3.1 Sanway Details
2.3.2 Sanway Major Business
2.3.3 Sanway Human Granulocyte Colony-stimulating Factor Product and Services
2.3.4 Sanway Human Granulocyte Colony-stimulating Factor Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.4 GenSci
2.4.1 GenSci Details
2.4.2 GenSci Major Business
2.4.3 GenSci Human Granulocyte Colony-stimulating Factor Product and Services
2.4.4 GenSci Human Granulocyte Colony-stimulating Factor Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.5 SL PHARM
2.5.1 SL PHARM Details
2.5.2 SL PHARM Major Business
2.5.3 SL PHARM Human Granulocyte Colony-stimulating Factor Product and Services
2.5.4 SL PHARM Human Granulocyte Colony-stimulating Factor Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.6 Kexing Bioproducts
2.6.1 Kexing Bioproducts Details
2.6.2 Kexing Bioproducts Major Business
2.6.3 Kexing Bioproducts Human Granulocyte Colony-stimulating Factor Product and Services
2.6.4 Kexing Bioproducts Human Granulocyte Colony-stimulating Factor Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.7 Qilu Pharmaceutical
2.7.1 Qilu Pharmaceutical Details
2.7.2 Qilu Pharmaceutical Major Business
2.7.3 Qilu Pharmaceutical Human Granulocyte Colony-stimulating Factor Product and Services
2.7.4 Qilu Pharmaceutical Human Granulocyte Colony-stimulating Factor Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.8 CSPC
2.8.1 CSPC Details
2.8.2 CSPC Major Business
2.8.3 CSPC Human Granulocyte Colony-stimulating Factor Product and Services
2.8.4 CSPC Human Granulocyte Colony-stimulating Factor Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.9 Wuzhong Pharmaceutical
2.9.1 Wuzhong Pharmaceutical Details
2.9.2 Wuzhong Pharmaceutical Major Business
2.9.3 Wuzhong Pharmaceutical Human Granulocyte Colony-stimulating Factor Product and Services
2.9.4 Wuzhong Pharmaceutical Human Granulocyte Colony-stimulating Factor Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.10 Quangang Pharmaceutical
2.10.1 Quangang Pharmaceutical Details
2.10.2 Quangang Pharmaceutical Major Business
2.10.3 Quangang Pharmaceutical Human Granulocyte Colony-stimulating Factor Product and Services
2.10.4 Quangang Pharmaceutical Human Granulocyte Colony-stimulating Factor Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.11 Huabei Pharmaceutical
2.11.1 Huabei Pharmaceutical Details
2.11.2 Huabei Pharmaceutical Major Business
2.11.3 Huabei Pharmaceutical Human Granulocyte Colony-stimulating Factor Product and Services
2.11.4 Huabei Pharmaceutical Human Granulocyte Colony-stimulating Factor Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.12 Harbin Pharmaceutical
2.12.1 Harbin Pharmaceutical Details
2.12.2 Harbin Pharmaceutical Major Business
2.12.3 Harbin Pharmaceutical Human Granulocyte Colony-stimulating Factor Product and Services
2.12.4 Harbin Pharmaceutical Human Granulocyte Colony-stimulating Factor Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.13 Amoytop Biotech
2.13.1 Amoytop Biotech Details
2.13.2 Amoytop Biotech Major Business
2.13.3 Amoytop Biotech Human Granulocyte Colony-stimulating Factor Product and Services
2.13.4 Amoytop Biotech Human Granulocyte Colony-stimulating Factor Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.14 Jiuyuan Gene Engineering
2.14.1 Jiuyuan Gene Engineering Details
2.14.2 Jiuyuan Gene Engineering Major Business
2.14.3 Jiuyuan Gene Engineering Human Granulocyte Colony-stimulating Factor Product and Services
2.14.4 Jiuyuan Gene Engineering Human Granulocyte Colony-stimulating Factor Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.15 Four Rings Biopharmaceutical
2.15.1 Four Rings Biopharmaceutical Details
2.15.2 Four Rings Biopharmaceutical Major Business
2.15.3 Four Rings Biopharmaceutical Human Granulocyte Colony-stimulating Factor Product and Services
2.15.4 Four Rings Biopharmaceutical Human Granulocyte Colony-stimulating Factor Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
3 Human Granulocyte Colony-stimulating Factor Breakdown Data by Manufacturer
3.1 Global Human Granulocyte Colony-stimulating Factor Sales in Volume by Manufacturer (2019, 2020, 2021, and 2022)
3.2 Global Human Granulocyte Colony-stimulating Factor Revenue by Manufacturer (2019, 2020, 2021, and 2022)
3.3 Key Manufacturer Market Position in Human Granulocyte Colony-stimulating Factor
3.4 Market Concentration Rate
3.4.1 Top 3 Human Granulocyte Colony-stimulating Factor Manufacturer Market Share in 2021
3.4.2 Top 6 Human Granulocyte Colony-stimulating Factor Manufacturer Market Share in 2021
3.5 Global Human Granulocyte Colony-stimulating Factor Production Capacity by Company: 2021 VS 2022
3.6 Manufacturer by Geography: Head Office and Human Granulocyte Colony-stimulating Factor Production Site
3.7 New Entrant and Capacity Expansion Plans
3.8 Mergers & Acquisitions
4 Market Analysis by Region
4.1 Global Human Granulocyte Colony-stimulating Factor Market Size by Region
4.1.1 Global Human Granulocyte Colony-stimulating Factor Sales in Volume by Region (2017-2028)
4.1.2 Global Human Granulocyte Colony-stimulating Factor Revenue by Region (2017-2028)
4.2 North America Human Granulocyte Colony-stimulating Factor Revenue (2017-2028)
4.3 Europe Human Granulocyte Colony-stimulating Factor Revenue (2017-2028)
4.4 Asia-Pacific Human Granulocyte Colony-stimulating Factor Revenue (2017-2028)
4.5 South America Human Granulocyte Colony-stimulating Factor Revenue (2017-2028)
4.6 Middle East and Africa Human Granulocyte Colony-stimulating Factor Revenue (2017-2028)
5 Market Segment by Type
5.1 Global Human Granulocyte Colony-stimulating Factor Sales in Volume by Type (2017-2028)
5.2 Global Human Granulocyte Colony-stimulating Factor Revenue by Type (2017-2028)
5.3 Global Human Granulocyte Colony-stimulating Factor Price by Type (2017-2028)
6 Market Segment by Application
6.1 Global Human Granulocyte Colony-stimulating Factor Sales in Volume by Application (2017-2028)
6.2 Global Human Granulocyte Colony-stimulating Factor Revenue by Application (2017-2028)
6.3 Global Human Granulocyte Colony-stimulating Factor Price by Application (2017-2028)
7 North America by Country, by Type, and by Application
7.1 North America Human Granulocyte Colony-stimulating Factor Sales by Type (2017-2028)
7.2 North America Human Granulocyte Colony-stimulating Factor Sales by Application (2017-2028)
7.3 North America Human Granulocyte Colony-stimulating Factor Market Size by Country
7.3.1 North America Human Granulocyte Colony-stimulating Factor Sales in Volume by Country (2017-2028)
7.3.2 North America Human Granulocyte Colony-stimulating Factor Revenue by Country (2017-2028)
7.3.3 United States Market Size and Forecast (2017-2028)
7.3.4 Canada Market Size and Forecast (2017-2028)
7.3.5 Mexico Market Size and Forecast (2017-2028)
8 Europe by Country, by Type, and by Application
8.1 Europe Human Granulocyte Colony-stimulating Factor Sales by Type (2017-2028)
8.2 Europe Human Granulocyte Colony-stimulating Factor Sales by Application (2017-2028)
8.3 Europe Human Granulocyte Colony-stimulating Factor Market Size by Country
8.3.1 Europe Human Granulocyte Colony-stimulating Factor Sales in Volume by Country (2017-2028)
8.3.2 Europe Human Granulocyte Colony-stimulating Factor Revenue by Country (2017-2028)
8.3.3 Germany Market Size and Forecast (2017-2028)
8.3.4 France Market Size and Forecast (2017-2028)
8.3.5 United Kingdom Market Size and Forecast (2017-2028)
8.3.6 Russia Market Size and Forecast (2017-2028)
8.3.7 Italy Market Size and Forecast (2017-2028)
9 Asia-Pacific by Region, by Type, and by Application
9.1 Asia-Pacific Human Granulocyte Colony-stimulating Factor Sales by Type (2017-2028)
9.2 Asia-Pacific Human Granulocyte Colony-stimulating Factor Sales by Application (2017-2028)
9.3 Asia-Pacific Human Granulocyte Colony-stimulating Factor Market Size by Region
9.3.1 Asia-Pacific Human Granulocyte Colony-stimulating Factor Sales in Volume by Region (2017-2028)
9.3.2 Asia-Pacific Human Granulocyte Colony-stimulating Factor Revenue by Region (2017-2028)
9.3.3 China Market Size and Forecast (2017-2028)
9.3.4 Japan Market Size and Forecast (2017-2028)
9.3.5 Korea Market Size and Forecast (2017-2028)
9.3.6 India Market Size and Forecast (2017-2028)
9.3.7 Southeast Asia Market Size and Forecast (2017-2028)
9.3.8 Australia Market Size and Forecast (2017-2028)
10 South America by Region, by Type, and by Application
10.1 South America Human Granulocyte Colony-stimulating Factor Sales by Type (2017-2028)
10.2 South America Human Granulocyte Colony-stimulating Factor Sales by Application (2017-2028)
10.3 South America Human Granulocyte Colony-stimulating Factor Market Size by Country
10.3.1 South America Human Granulocyte Colony-stimulating Factor Sales in Volume by Country (2017-2028)
10.3.2 South America Human Granulocyte Colony-stimulating Factor Revenue by Country (2017-2028)
10.3.3 Brazil Market Size and Forecast (2017-2028)
10.3.4 Argentina Market Size and Forecast (2017-2028)
11 Middle East & Africa by Country, by Type, and by Application
11.1 Middle East & Africa Human Granulocyte Colony-stimulating Factor Sales by Type (2017-2028)
11.2 Middle East & Africa Human Granulocyte Colony-stimulating Factor Sales by Application (2017-2028)
11.3 Middle East & Africa Human Granulocyte Colony-stimulating Factor Market Size by Country
11.3.1 Middle East & Africa Human Granulocyte Colony-stimulating Factor Sales in Volume by Country (2017-2028)
11.3.2 Middle East & Africa Human Granulocyte Colony-stimulating Factor Revenue by Country (2017-2028)
11.3.3 Turkey Market Size and Forecast (2017-2028)
11.3.4 Egypt Market Size and Forecast (2017-2028)
11.3.5 Saudi Arabia Market Size and Forecast (2017-2028)
11.3.6 South Africa Market Size and Forecast (2017-2028)
12 Raw Material and Industry Chain
12.1 Raw Material of Human Granulocyte Colony-stimulating Factor and Key Manufacturers
12.2 Manufacturing Costs Percentage of Human Granulocyte Colony-stimulating Factor
12.3 Human Granulocyte Colony-stimulating Factor Production Process
12.4 Human Granulocyte Colony-stimulating Factor Industrial Chain
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.2 Human Granulocyte Colony-stimulating Factor Typical Distributors
13.3 Human Granulocyte Colony-stimulating Factor Typical Customers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Research Process and Data Source
15.3 Disclaimer

List of Tables
Table 1. Global Human Granulocyte Colony-stimulating Factor Revenue by Type, (USD Million), 2017 & 2021 & 2028
Table 2. Global Human Granulocyte Colony-stimulating Factor Revenue by Application, (USD Million), 2017 & 2021 & 2028
Table 3. Chugai Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 4. Chugai Pharmaceutical Major Business
Table 5. Chugai Pharmaceutical Human Granulocyte Colony-stimulating Factor Product and Services
Table 6. Chugai Pharmaceutical Human Granulocyte Colony-stimulating Factor Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 7. Kyowa Hakko Kirin Basic Information, Manufacturing Base and Competitors
Table 8. Kyowa Hakko Kirin Major Business
Table 9. Kyowa Hakko Kirin Human Granulocyte Colony-stimulating Factor Product and Services
Table 10. Kyowa Hakko Kirin Human Granulocyte Colony-stimulating Factor Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 11. Sanway Basic Information, Manufacturing Base and Competitors
Table 12. Sanway Major Business
Table 13. Sanway Human Granulocyte Colony-stimulating Factor Product and Services
Table 14. Sanway Human Granulocyte Colony-stimulating Factor Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 15. GenSci Basic Information, Manufacturing Base and Competitors
Table 16. GenSci Major Business
Table 17. GenSci Human Granulocyte Colony-stimulating Factor Product and Services
Table 18. GenSci Human Granulocyte Colony-stimulating Factor Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 19. SL PHARM Basic Information, Manufacturing Base and Competitors
Table 20. SL PHARM Major Business
Table 21. SL PHARM Human Granulocyte Colony-stimulating Factor Product and Services
Table 22. SL PHARM Human Granulocyte Colony-stimulating Factor Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 23. Kexing Bioproducts Basic Information, Manufacturing Base and Competitors
Table 24. Kexing Bioproducts Major Business
Table 25. Kexing Bioproducts Human Granulocyte Colony-stimulating Factor Product and Services
Table 26. Kexing Bioproducts Human Granulocyte Colony-stimulating Factor Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 27. Qilu Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 28. Qilu Pharmaceutical Major Business
Table 29. Qilu Pharmaceutical Human Granulocyte Colony-stimulating Factor Product and Services
Table 30. Qilu Pharmaceutical Human Granulocyte Colony-stimulating Factor Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 31. CSPC Basic Information, Manufacturing Base and Competitors
Table 32. CSPC Major Business
Table 33. CSPC Human Granulocyte Colony-stimulating Factor Product and Services
Table 34. CSPC Human Granulocyte Colony-stimulating Factor Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 35. Wuzhong Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 36. Wuzhong Pharmaceutical Major Business
Table 37. Wuzhong Pharmaceutical Human Granulocyte Colony-stimulating Factor Product and Services
Table 38. Wuzhong Pharmaceutical Human Granulocyte Colony-stimulating Factor Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 39. Quangang Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 40. Quangang Pharmaceutical Major Business
Table 41. Quangang Pharmaceutical Human Granulocyte Colony-stimulating Factor Product and Services
Table 42. Quangang Pharmaceutical Human Granulocyte Colony-stimulating Factor Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 43. Huabei Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 44. Huabei Pharmaceutical Major Business
Table 45. Huabei Pharmaceutical Human Granulocyte Colony-stimulating Factor Product and Services
Table 46. Huabei Pharmaceutical Human Granulocyte Colony-stimulating Factor Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 47. Harbin Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 48. Harbin Pharmaceutical Major Business
Table 49. Harbin Pharmaceutical Human Granulocyte Colony-stimulating Factor Product and Services
Table 50. Harbin Pharmaceutical Human Granulocyte Colony-stimulating Factor Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 51. Amoytop Biotech Basic Information, Manufacturing Base and Competitors
Table 52. Amoytop Biotech Major Business
Table 53. Amoytop Biotech Human Granulocyte Colony-stimulating Factor Product and Services
Table 54. Amoytop Biotech Human Granulocyte Colony-stimulating Factor Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 55. Jiuyuan Gene Engineering Basic Information, Manufacturing Base and Competitors
Table 56. Jiuyuan Gene Engineering Major Business
Table 57. Jiuyuan Gene Engineering Human Granulocyte Colony-stimulating Factor Product and Services
Table 58. Jiuyuan Gene Engineering Human Granulocyte Colony-stimulating Factor Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 59. Four Rings Biopharmaceutical Basic Information, Manufacturing Base and Competitors
Table 60. Four Rings Biopharmaceutical Major Business
Table 61. Four Rings Biopharmaceutical Human Granulocyte Colony-stimulating Factor Product and Services
Table 62. Four Rings Biopharmaceutical Human Granulocyte Colony-stimulating Factor Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 63. Global Human Granulocyte Colony-stimulating Factor Sales by Manufacturer (2019, 2020, 2021, and 2022) & (K Units)
Table 64. Global Human Granulocyte Colony-stimulating Factor Revenue by Manufacturer (2019, 2020, 2021, and 2022) & (USD Million)
Table 65. Market Position of Manufacturers in Human Granulocyte Colony-stimulating Factor, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2021
Table 66. Global Human Granulocyte Colony-stimulating Factor Production Capacity by Company, (K Units): 2020 VS 2021
Table 67. Head Office and Human Granulocyte Colony-stimulating Factor Production Site of Key Manufacturer
Table 68. Human Granulocyte Colony-stimulating Factor New Entrant and Capacity Expansion Plans
Table 69. Human Granulocyte Colony-stimulating Factor Mergers & Acquisitions in the Past Five Years
Table 70. Global Human Granulocyte Colony-stimulating Factor Sales by Region (2017-2022) & (K Units)
Table 71. Global Human Granulocyte Colony-stimulating Factor Sales by Region (2023-2028) & (K Units)
Table 72. Global Human Granulocyte Colony-stimulating Factor Revenue by Region (2017-2022) & (USD Million)
Table 73. Global Human Granulocyte Colony-stimulating Factor Revenue by Region (2023-2028) & (USD Million)
Table 74. Global Human Granulocyte Colony-stimulating Factor Sales by Type (2017-2022) & (K Units)
Table 75. Global Human Granulocyte Colony-stimulating Factor Sales by Type (2023-2028) & (K Units)
Table 76. Global Human Granulocyte Colony-stimulating Factor Revenue by Type (2017-2022) & (USD Million)
Table 77. Global Human Granulocyte Colony-stimulating Factor Revenue by Type (2023-2028) & (USD Million)
Table 78. Global Human Granulocyte Colony-stimulating Factor Price by Type (2017-2022) & (US$/Unit)
Table 79. Global Human Granulocyte Colony-stimulating Factor Price by Type (2023-2028) & (US$/Unit)
Table 80. Global Human Granulocyte Colony-stimulating Factor Sales by Application (2017-2022) & (K Units)
Table 81. Global Human Granulocyte Colony-stimulating Factor Sales by Application (2023-2028) & (K Units)
Table 82. Global Human Granulocyte Colony-stimulating Factor Revenue by Application (2017-2022) & (USD Million)
Table 83. Global Human Granulocyte Colony-stimulating Factor Revenue by Application (2023-2028) & (USD Million)
Table 84. Global Human Granulocyte Colony-stimulating Factor Price by Application (2017-2022) & (US$/Unit)
Table 85. Global Human Granulocyte Colony-stimulating Factor Price by Application (2023-2028) & (US$/Unit)
Table 86. North America Human Granulocyte Colony-stimulating Factor Sales by Country (2017-2022) & (K Units)
Table 87. North America Human Granulocyte Colony-stimulating Factor Sales by Country (2023-2028) & (K Units)
Table 88. North America Human Granulocyte Colony-stimulating Factor Revenue by Country (2017-2022) & (USD Million)
Table 89. North America Human Granulocyte Colony-stimulating Factor Revenue by Country (2023-2028) & (USD Million)
Table 90. North America Human Granulocyte Colony-stimulating Factor Sales by Type (2017-2022) & (K Units)
Table 91. North America Human Granulocyte Colony-stimulating Factor Sales by Type (2023-2028) & (K Units)
Table 92. North America Human Granulocyte Colony-stimulating Factor Sales by Application (2017-2022) & (K Units)
Table 93. North America Human Granulocyte Colony-stimulating Factor Sales by Application (2023-2028) & (K Units)
Table 94. Europe Human Granulocyte Colony-stimulating Factor Sales by Country (2017-2022) & (K Units)
Table 95. Europe Human Granulocyte Colony-stimulating Factor Sales by Country (2023-2028) & (K Units)
Table 96. Europe Human Granulocyte Colony-stimulating Factor Revenue by Country (2017-2022) & (USD Million)
Table 97. Europe Human Granulocyte Colony-stimulating Factor Revenue by Country (2023-2028) & (USD Million)
Table 98. Europe Human Granulocyte Colony-stimulating Factor Sales by Type (2017-2022) & (K Units)
Table 99. Europe Human Granulocyte Colony-stimulating Factor Sales by Type (2023-2028) & (K Units)
Table 100. Europe Human Granulocyte Colony-stimulating Factor Sales by Application (2017-2022) & (K Units)
Table 101. Europe Human Granulocyte Colony-stimulating Factor Sales by Application (2023-2028) & (K Units)
Table 102. Asia-Pacific Human Granulocyte Colony-stimulating Factor Sales by Region (2017-2022) & (K Units)
Table 103. Asia-Pacific Human Granulocyte Colony-stimulating Factor Sales by Region (2023-2028) & (K Units)
Table 104. Asia-Pacific Human Granulocyte Colony-stimulating Factor Revenue by Region (2017-2022) & (USD Million)
Table 105. Asia-Pacific Human Granulocyte Colony-stimulating Factor Revenue by Region (2023-2028) & (USD Million)
Table 106. Asia-Pacific Human Granulocyte Colony-stimulating Factor Sales by Type (2017-2022) & (K Units)
Table 107. Asia-Pacific Human Granulocyte Colony-stimulating Factor Sales by Type (2023-2028) & (K Units)
Table 108. Asia-Pacific Human Granulocyte Colony-stimulating Factor Sales by Application (2017-2022) & (K Units)
Table 109. Asia-Pacific Human Granulocyte Colony-stimulating Factor Sales by Application (2023-2028) & (K Units)
Table 110. South America Human Granulocyte Colony-stimulating Factor Sales by Country (2017-2022) & (K Units)
Table 111. South America Human Granulocyte Colony-stimulating Factor Sales by Country (2023-2028) & (K Units)
Table 112. South America Human Granulocyte Colony-stimulating Factor Revenue by Country (2017-2022) & (USD Million)
Table 113. South America Human Granulocyte Colony-stimulating Factor Revenue by Country (2023-2028) & (USD Million)
Table 114. South America Human Granulocyte Colony-stimulating Factor Sales by Type (2017-2022) & (K Units)
Table 115. South America Human Granulocyte Colony-stimulating Factor Sales by Type (2023-2028) & (K Units)
Table 116. South America Human Granulocyte Colony-stimulating Factor Sales by Application (2017-2022) & (K Units)
Table 117. South America Human Granulocyte Colony-stimulating Factor Sales by Application (2023-2028) & (K Units)
Table 118. Middle East & Africa Human Granulocyte Colony-stimulating Factor Sales by Region (2017-2022) & (K Units)
Table 119. Middle East & Africa Human Granulocyte Colony-stimulating Factor Sales by Region (2023-2028) & (K Units)
Table 120. Middle East & Africa Human Granulocyte Colony-stimulating Factor Revenue by Region (2017-2022) & (USD Million)
Table 121. Middle East & Africa Human Granulocyte Colony-stimulating Factor Revenue by Region (2023-2028) & (USD Million)
Table 122. Middle East & Africa Human Granulocyte Colony-stimulating Factor Sales by Type (2017-2022) & (K Units)
Table 123. Middle East & Africa Human Granulocyte Colony-stimulating Factor Sales by Type (2023-2028) & (K Units)
Table 124. Middle East & Africa Human Granulocyte Colony-stimulating Factor Sales by Application (2017-2022) & (K Units)
Table 125. Middle East & Africa Human Granulocyte Colony-stimulating Factor Sales by Application (2023-2028) & (K Units)
Table 126. Human Granulocyte Colony-stimulating Factor Raw Material
Table 127. Key Manufacturers of Human Granulocyte Colony-stimulating Factor Raw Materials
Table 128. Direct Channel Pros & Cons
Table 129. Indirect Channel Pros & Cons
Table 130. Human Granulocyte Colony-stimulating Factor Typical Distributors
Table 131. Human Granulocyte Colony-stimulating Factor Typical Customers
List of Figures
Figure 1. Human Granulocyte Colony-stimulating Factor Picture
Figure 2. Global Human Granulocyte Colony-stimulating Factor Revenue Market Share by Type in 2021
Figure 3. 300μg/Dose
Figure 4. 150μg/Dose
Figure 5. 75μg/Dose
Figure 6. Others
Figure 7. Global Human Granulocyte Colony-stimulating Factor Revenue Market Share by Application in 2021
Figure 8. Hospital
Figure 9. Clinic
Figure 10. Global Human Granulocyte Colony-stimulating Factor Revenue, (USD Million) & (K Units): 2017 & 2021 & 2028
Figure 11. Global Human Granulocyte Colony-stimulating Factor Revenue and Forecast (2017-2028) & (USD Million)
Figure 12. Global Human Granulocyte Colony-stimulating Factor Sales (2017-2028) & (K Units)
Figure 13. Global Human Granulocyte Colony-stimulating Factor Price (2017-2028) & (US$/Unit)
Figure 14. Global Human Granulocyte Colony-stimulating Factor Production Capacity (2017-2028) & (K Units)
Figure 15. Global Human Granulocyte Colony-stimulating Factor Production Capacity by Geographic Region: 2022 VS 2028
Figure 16. Human Granulocyte Colony-stimulating Factor Market Drivers
Figure 17. Human Granulocyte Colony-stimulating Factor Market Restraints
Figure 18. Human Granulocyte Colony-stimulating Factor Market Trends
Figure 19. Global Human Granulocyte Colony-stimulating Factor Sales Market Share by Manufacturer in 2021
Figure 20. Global Human Granulocyte Colony-stimulating Factor Revenue Market Share by Manufacturer in 2021
Figure 21. Human Granulocyte Colony-stimulating Factor Market Share by Company Type (Tier 1, Tier 2, and Tier 3) in 2021
Figure 22. Top 3 Human Granulocyte Colony-stimulating Factor Manufacturer (Revenue) Market Share in 2021
Figure 23. Top 6 Human Granulocyte Colony-stimulating Factor Manufacturer (Revenue) Market Share in 2021
Figure 24. Global Human Granulocyte Colony-stimulating Factor Sales Market Share by Region (2017-2028)
Figure 25. Global Human Granulocyte Colony-stimulating Factor Revenue Market Share by Region (2017-2028)
Figure 26. North America Human Granulocyte Colony-stimulating Factor Revenue (2017-2028) & (USD Million)
Figure 27. Europe Human Granulocyte Colony-stimulating Factor Revenue (2017-2028) & (USD Million)
Figure 28. Asia-Pacific Human Granulocyte Colony-stimulating Factor Revenue (2017-2028) & (USD Million)
Figure 29. South America Human Granulocyte Colony-stimulating Factor Revenue (2017-2028) & (USD Million)
Figure 30. Middle East & Africa Human Granulocyte Colony-stimulating Factor Revenue (2017-2028) & (USD Million)
Figure 31. Global Human Granulocyte Colony-stimulating Factor Sales Market Share by Type (2017-2028)
Figure 32. Global Human Granulocyte Colony-stimulating Factor Revenue Market Share by Type (2017-2028)
Figure 33. Global Human Granulocyte Colony-stimulating Factor Price by Type (2017-2028) & (US$/Unit)
Figure 34. Global Human Granulocyte Colony-stimulating Factor Sales Market Share by Application (2017-2028)
Figure 35. Global Human Granulocyte Colony-stimulating Factor Revenue Market Share by Application (2017-2028)
Figure 36. Global Human Granulocyte Colony-stimulating Factor Price by Application (2017-2028) & (US$/Unit)
Figure 37. North America Human Granulocyte Colony-stimulating Factor Sales Market Share by Type (2017-2028)
Figure 38. North America Human Granulocyte Colony-stimulating Factor Sales Market Share by Application (2017-2028)
Figure 39. North America Human Granulocyte Colony-stimulating Factor Sales Market Share by Country (2017-2028)
Figure 40. North America Human Granulocyte Colony-stimulating Factor Revenue Market Share by Country (2017-2028)
Figure 41. United States Human Granulocyte Colony-stimulating Factor Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 42. Canada Human Granulocyte Colony-stimulating Factor Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 43. Mexico Human Granulocyte Colony-stimulating Factor Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 44. Europe Human Granulocyte Colony-stimulating Factor Sales Market Share by Type (2017-2028)
Figure 45. Europe Human Granulocyte Colony-stimulating Factor Sales Market Share by Application (2017-2028)
Figure 46. Europe Human Granulocyte Colony-stimulating Factor Sales Market Share by Country (2017-2028)
Figure 47. Europe Human Granulocyte Colony-stimulating Factor Revenue Market Share by Country (2017-2028)
Figure 48. Germany Human Granulocyte Colony-stimulating Factor Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 49. France Human Granulocyte Colony-stimulating Factor Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 50. United Kingdom Human Granulocyte Colony-stimulating Factor Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 51. Russia Human Granulocyte Colony-stimulating Factor Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 52. Italy Human Granulocyte Colony-stimulating Factor Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 53. Asia-Pacific Human Granulocyte Colony-stimulating Factor Sales Market Share by Region (2017-2028)
Figure 54. Asia-Pacific Human Granulocyte Colony-stimulating Factor Sales Market Share by Application (2017-2028)
Figure 55. Asia-Pacific Human Granulocyte Colony-stimulating Factor Sales Market Share by Region (2017-2028)
Figure 56. Asia-Pacific Human Granulocyte Colony-stimulating Factor Revenue Market Share by Region (2017-2028)
Figure 57. China Human Granulocyte Colony-stimulating Factor Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 58. Japan Human Granulocyte Colony-stimulating Factor Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 59. Korea Human Granulocyte Colony-stimulating Factor Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 60. India Human Granulocyte Colony-stimulating Factor Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 61. Southeast Asia Human Granulocyte Colony-stimulating Factor Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 62. Australia Human Granulocyte Colony-stimulating Factor Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 63. South America Human Granulocyte Colony-stimulating Factor Sales Market Share by Type (2017-2028)
Figure 64. South America Human Granulocyte Colony-stimulating Factor Sales Market Share by Application (2017-2028)
Figure 65. South America Human Granulocyte Colony-stimulating Factor Sales Market Share by Country (2017-2028)
Figure 66. South America Human Granulocyte Colony-stimulating Factor Revenue Market Share by Country (2017-2028)
Figure 67. Brazil Human Granulocyte Colony-stimulating Factor Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 68. Argentina Human Granulocyte Colony-stimulating Factor Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 69. Middle East & Africa Human Granulocyte Colony-stimulating Factor Sales Market Share by Type (2017-2028)
Figure 70. Middle East & Africa Human Granulocyte Colony-stimulating Factor Sales Market Share by Application (2017-2028)
Figure 71. Middle East & Africa Human Granulocyte Colony-stimulating Factor Sales Market Share by Region (2017-2028)
Figure 72. Middle East & Africa Human Granulocyte Colony-stimulating Factor Revenue Market Share by Region (2017-2028)
Figure 73. Turkey Human Granulocyte Colony-stimulating Factor Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 74. Egypt Human Granulocyte Colony-stimulating Factor Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 75. Saudi Arabia Human Granulocyte Colony-stimulating Factor Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 76. South Africa Human Granulocyte Colony-stimulating Factor Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 77. Manufacturing Cost Structure Analysis of Human Granulocyte Colony-stimulating Factor in 2021
Figure 78. Manufacturing Process Analysis of Human Granulocyte Colony-stimulating Factor
Figure 79. Human Granulocyte Colony-stimulating Factor Industrial Chain
Figure 80. Sales Channel: Direct Channel vs Indirect Channel
Figure 81. Methodology
Figure 82. Research Process and Data Source

❖ 免責事項 ❖
http://www.globalresearch.jp/disclaimer

★リサーチレポート[ ヒト顆粒球コロニー刺激因子の世界市場2022：300μg/回、150μg/回、75μg/回、その他(Global Human Granulocyte Colony-stimulating Factor Market 2022 by Manufacturers, Regions, Type and Application, Forecast to 2028)]についてメールでお問い合わせはこちらでお願いします。

GlobalResearch.jp

ヒト顆粒球コロニー刺激因子の世界市場2022：300μg/回、150μg/回、75μg/回、その他

グローバル市場調査/マーケットリサーチ会社：レポート販売と委託調査サービス提供 www.GlobalResearch.jp